Valstar Preservative Free en es it fr

Valstar Preservative Free Brand names, Valstar Preservative Free Analogs

Valstar Preservative Free Brand Names Mixture

  • No information avaliable

Valstar Preservative Free Chemical_Formula

C34H36F3NO13

Valstar Preservative Free RX_link

http://www.rxlist.com/cgi/generic2/rubicin.htm

Valstar Preservative Free fda sheet

Valstar_Preservative_Free FDA

Valstar Preservative Free msds (material safety sheet)

Valstar Preservative Free Synthesis Reference

No information avaliable

Valstar Preservative Free Molecular Weight

723.644 g/mol

Valstar Preservative Free Melting Point

116-117oC

Valstar Preservative Free H2O Solubility

insoluble

Valstar Preservative Free State

Solid

Valstar Preservative Free LogP

3.332

Valstar Preservative Free Dosage Forms

Liquid

Valstar Preservative Free Indication

Bladder cancer

Valstar Preservative Free Pharmacology

When 800 mg Valstar was administered intravesically to patients with carcinoma in situ, Valstar penetrated into the bladder wall. The mean total anthracycline concentration measured in bladder tissue exceeded the levels causing 90% cytoxicity to human bladder cells cultured in vitro. During the two-hour dose-retention period, the metabolism of Valstar to its major metabolites N-trifluoroacetyladriamycin and N-trifluoroacetyladriamycinol was neglible. After retention, the drug was almost completely excreted by voiding the instillate. Mean percent recovery of Valstar, N-trifluoroacetyladriamycin, and total anthracyclines in 14 urine samples from six patients was 98.6%, 0.4%, and 99.0% of the total administered drug, respectively. During the two-hour dose-retention period, only nanogram quantities of Valstar were absorbed into the plasma.

Valstar Preservative Free Absorption

No information avaliable

Valstar Preservative Free side effects and Toxicity

No information avaliable

Valstar Preservative Free Patient Information

Valstar Preservative Free Organisms Affected

Humans and other mammals